期刊
FRONTIERS IN IMMUNOLOGY
卷 10, 期 -, 页码 -出版社
FRONTIERS MEDIA SA
DOI: 10.3389/fimmu.2019.01848
关键词
oncolytic viruses; H-1PV; immunotherapy; immunogenic cell death; combination therapy; tumor microenvironment; checkpoint blockade
类别
资金
- Luxembourg Cancer Foundation
- Televie
- Oryx GmbH
Cancer cells utilize multiple mechanisms to evade and suppress anticancer immune responses creating a cold immunosuppressive tumor microenvironment. Oncolytic virotherapy is emerging as a promising approach to revert tumor immunosuppression and enhance the efficacy of other forms of immunotherapy. Growing evidence indicates that oncolytic viruses (OVs) act in a multimodal fashion, inducing immunogenic cell death and thereby eliciting robust anticancer immune responses. In this review, we summarize information about OV-mediated immune conversion of the tumormicroenvironment. As a case study we focus on the rodent protoparvovirus H-1PV and its dual role as an oncolytic and immunemodulatory agent. Potential strategies to improve H-1PV anticancer efficacy are also discussed.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据